<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02296632</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00036773</org_study_id>
    <nct_id>NCT02296632</nct_id>
  </id_info>
  <brief_title>Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study</brief_title>
  <official_title>Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study and Preliminary Validation Effort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cedars-Sinai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cedars-Sinai Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to provide preliminary evidence of the validity of a sensor-based assessment
      of rheumatoid arthritis (RA) symptoms, and to collect structured qualitative feedback from RA
      Enbrel patients regarding the potential of a future biosensor/PRO mHealth application. The
      investigators' overarching hypothesis is that if patients have better and more timely
      information about whether Enbrel is working, then they will become more empowered and engaged
      in their treatment, more curious about how it may - or may not - be working, and potentially
      more compliant with therapy. However, this hypothesis remains largely untested.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with rheumatoid arthritis (RA) often endure a remitting and flaring disease-course
      characterized by considerable pain, stiffness, and fatigue. The social and emotional
      well-being of RA patients can suffer as a result. Data demonstrate that adherence to Enbrel
      significantly improves both functional status and health related quality of life (HRQOL) in
      RA patients. Yet patients prescribed Enbrel often exhibit non-adherence through early
      discontinuation, dose-stretching, and reduced persistence following medication &quot;holidays&quot;.
      The knowledge, attitudes, and beliefs held by patients with regard to RA and Enbrel influence
      their perceptions of the benefits of, and barriers to, treatment.

      Decisions to adhere occur when combined levels of susceptibility and severity provide the
      motivation to act, and the perception of benefits (less barriers) indicates a path of action.
      A given patient's ability to follow this path of action hinges on their relative
      self-efficacy: the conviction that they can successfully execute a behavior required to
      produce an expected outcome. Landscape literature reviews conducted by CORE-UCLA suggest that
      interventions targeting self-efficacy offer the greatest chance of improving adherence to
      Enbrel. Self-efficacy plays an important mediating role in self-management activities,
      allowing for the adoption and maintenance of health behaviors. Many studies have identified
      measures of self-efficacy as significant predictors of adherence in RA patients. Additionally
      - though with the caveat that they are methodologically heterogeneous and of limited
      generalizability - a number of studies have found that interventions targeting self-efficacy
      can significantly improve adherence related outcomes. Seminal works in the field - including
      Bandura's Social Cognition Theory and Rosenstock's Health Beliefs Model - have converged on
      the following recommendations for behavioral interventions targeting self-efficacy:

        1. Identify and reinforce the patient's past and present successes or accomplishments.

        2. Direct patients to observe successful behaviors and coping mechanisms of similar others,
           even if this involves having them alter or expand their social network.

        3. Provide positive feedback for the patient's efforts or encourage people in the patient's
           social network, such as family members or friends, to do this.

        4. Facilitate the patient in adopting new health behaviors by ensuring that patients do not
           interpret incorrectly how they are feeling.

      Enabled by recent advances in microelectronics, signal processing algorithms, and networking
      capabilities, wireless health technologies hold the potential to support numerous aspects of
      these recommendations. Namely, motion sensors might contribute to the formation of a complete
      feedback loop involving self- monitoring, data presentation, and tailored messaging. Consumer
      Health Informatics (CHI) applications that offer complete feedback loops hold the most
      promise for improving self-efficacy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Qualitative measures of intervention experience</measure>
    <time_frame>28 days</time_frame>
    <description>We will conduct in-person interviews with participants to learn about their experiences wearing motion sensors and completing daily online assessments.</description>
  </primary_outcome>
  <enrollment type="Actual">7</enrollment>
  <condition>Arthritis, Rheumatoid</condition>
  <condition>Medication Adherence</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motion sensors and daily online assessments</intervention_name>
    <description>Patients will be asked to wear motion sensors during their waking hours and complete daily Patient Reported Outcomes online assessments.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with rheumatoid arthritis who are candidates to undergo treatment with the drug
        etanercept.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Enbrel users between week -2 and week 5 of therapy, inclusive.

          -  Current active prescription for Enbrel with intent to use.

          -  21 years or older.

          -  English speaking

          -  Have an understanding, ability, and willingness to fully comply with study procedures
             and restrictions.

        Exclusion Criteria:

          -  Allergic to latex or dry natural rubber

          -  Using a pacemaker, implantable cardiac defibrillator, neurostimulator, hearing aids,
             cochlear implants or other electronic medical equipment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brennan Spiegel, MD, MSHS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cedars-Sinai Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Rosenstock, I. M. (1974). The health belief model and preventive health behavior. Health Education &amp; Behavior, 2, 354-386.</citation>
  </reference>
  <reference>
    <citation>Bandura, A. (1996). Social foundations of thought and action: A social cognitive theory. Englewood Cliffs, NJ: Prentice Hall.</citation>
  </reference>
  <reference>
    <citation>Brus H, van de Laar M, Taal E, Rasker J, Wiegman O. Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient Educ Couns. 1999 Jan;36(1):57-64.</citation>
    <PMID>10036560</PMID>
  </reference>
  <reference>
    <citation>Taal E, Rasker JJ, Seydel ER, Wiegman O. Health status, adherence with health recommendations, self-efficacy and social support in patients with rheumatoid arthritis. Patient Educ Couns. 1993 May;20(2-3):63-76.</citation>
    <PMID>8337196</PMID>
  </reference>
  <reference>
    <citation>Marks R, Allegrante JP, Lorig K. A review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: implications for health education practice (part I). Health Promot Pract. 2005 Jan;6(1):37-43. Review.</citation>
    <PMID>15574526</PMID>
  </reference>
  <reference>
    <citation>Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q. 1988 Summer;15(2):175-83.</citation>
    <PMID>3378902</PMID>
  </reference>
  <reference>
    <citation>Gibbons, M. C., Wilson, R. F., Samal, L., Lehmann, C. U., Dickersin, K., Lehmann, H. P., Bass, E. B. (2009). Impact of consumer health informatics applications (Executive Summary). Rockville, MD: Agency for Healthcare Research and Quality. Retrieved from: http://www.ncbi.nlm.nih.gov/books/NBK32641/</citation>
  </reference>
  <reference>
    <citation>Campbell, D. &amp; Stanley, J. (1963). Experimental and quasi-experimental designs for research. Chicago, IL: Rand-McNally.</citation>
  </reference>
  <reference>
    <citation>Christodoulou C, Schneider S, Junghaenel DU, Broderick JE, Stone AA. Measuring daily fatigue using a brief scale adapted from the Patient-Reported Outcomes Measurement Information System (PROMIS Â®). Qual Life Res. 2014 May;23(4):1245-53. doi: 10.1007/s11136-013-0553-z. Epub 2013 Oct 17.</citation>
    <PMID>24132347</PMID>
  </reference>
  <reference>
    <citation>Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum. 1989 Jan;32(1):37-44.</citation>
    <PMID>2912463</PMID>
  </reference>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2014</study_first_submitted>
  <study_first_submitted_qc>November 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2014</study_first_posted>
  <last_update_submitted>August 18, 2015</last_update_submitted>
  <last_update_submitted_qc>August 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cedars-Sinai Medical Center</investigator_affiliation>
    <investigator_full_name>Brennan Spiegel</investigator_full_name>
    <investigator_title>Director of Health Services Research</investigator_title>
  </responsible_party>
  <keyword>Telemedicine</keyword>
  <keyword>Patient Reported Outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

